EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. (2019)

First Author: Thomas DC
Attributed to:  A BIOMARKER AND PATHWAY DISCOVERY PROGRAMME IN INFLAMMATORY DISEASE funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2018.09.019

PubMed Identifier: 30312704

Publication URI: http://europepmc.org/abstract/MED/30312704

Type: Journal Article/Review

Volume: 143

Parent Publication: The Journal of allergy and clinical immunology

Issue: 2

ISSN: 0091-6749